肺结核合并呼吸衰竭脑钠肽浓度变化的临床意义

doi:10.3969/j.issn.1000-8535.2016.01.002

摘要/Abstract

摘要： 目的探讨脑钠肽(BNP)在协助判断肺结核合并呼吸衰竭疗效及预后的价值。方法 2013年1月—2014年12月我院收治初治菌阳肺结核合并呼衰共81例,分别在抗结核、呼衰治疗前及2 周末行BNP、动脉血气分析及胸部X线检查;按住院号对应随机数字表随机抽取我院同期初治菌阳肺结核无合并呼衰104例作为对照组,采集两组数据进行回顾性病例对照研究。结果肺结核合并呼衰BNP高于单纯肺结核11.4倍(1115.11 pg/mL比97.60 pg/mL),全肺结核高于非全肺结核3.4倍(1549.82 pg/mL比449.47 pg/mL)。治疗前BNP与PaO₂、SaO₂和pH值呈负相关,与PaCO₂呈正相关,治疗后两者无相关性。2周末 BNP是治疗前0.57倍(632.41 pg/mL比1115.11 pg/mL),死亡组高于存活组8.7倍(3119.63 pg/mL比359.84 pg/mL)。结论肺结核合并呼衰BNP升高,治疗后随病情好转持续下降,有可能成为协助判断疗效及估测预后的指标之一。

关键词: 肺结核, 呼吸衰竭, 脑钠肽(BNP), 疗效, 预后

Abstract: Objective Discussion about value of brain natriuretic peptide (BNP) in helping to determine the efficacy and prognostic of pulmonary tuberculosis combine with respiratory failure. Methods 81 cases were admitted from January 2013 to December 2014 in our hospital of early treatment sputum positive pulmonary tuberculosis with respiratory failure. And the cases were carried out BNP, arterial blood gas analysis and chest X-ray before treatment and after two weeks respectively.104 cases of earlier sputum positive pulmonary tuberculosis accompanied with respiratory failure were randomly drawn according to the corresponding random number of hospitalization as a control group. Two sets of data were collected to conduct retrospective case-control study. Results BNP of pulmonary tuberculosis combine with respiratory failure is 11.4 times higher than that of tuberculosis alone (1115.11 pg/mL compare 97.60 pg/mL), the whole TB is 3.4 times higher than non-full-tuberculosis (1549.82 pg/mL t compare 449.47 pg/mL). Before treatment, BNP was negatively correlated to PaO₂, SaO₂ and pH BNP was positively correlated with PaCO₂. There was no correlation after treatment between BNP and PaCO₂.After two weeks BNP is 0.57 times of the pre-treatment (632.41 pg/mL compared 1115.11 pg/mL). The group of death is 8.7 times higher than the survival group (3119.63 pg/mL compared 359.84 pg/mL). Conclusion BNP was significantly increased in patient accompanied tuberculosis with respiratory failure .The condition is continued to decline after treatment. There is likely to be one of the indicators of helping to determine the efficacy and estimate prognosis.

Key words: Tuberculosis, Respiratory failure, Brain natriuretic peptide (BNP), Efficacy, Prognosis

卫安娜, 杜正新, 庞慧敏. 肺结核合并呼吸衰竭脑钠肽浓度变化的临床意义[J]. 广州医药, 2016, 47(1): 6-8.

Wei Anna, Du Zhengxin, Pang Huimin. Clinical significance in changes of brain natriuretic peptide concentration in pulmonary tuberculosis combine with respiratory failure[J]. Guangzhou Medical Journal, 2016, 47(1): 6-8.

参考文献

[1] 杨澄清,陆兰英. 脑钠肽在心血管及呼吸系统中的临床应用[J]. 医学综述, 2012,8(18):2364-2367.
[2] 应晟,杨美云. B型利钠肽在诊断非心源性危重症病人预后中的意义[J]. 上海预防医学杂志,2011,6(23):306-307.
[3] 陈传华,马祥波,刘俊峰,等.联合检测慢性阻塞性肺NT－Pro BNP、PCT及D二聚体水平的价值[J]. 现代医院,2015,5(15):93-95.
[4] 王骥.血浆脑钠肽测定在慢性阻塞性肺疾病合并急性呼吸困难病因鉴别的临床意义[J]. 蚌埠医学院学报,2014,8(39):1034-1036.
[5] 何喜军,石源.脑钠肽在慢性阻塞性肺疾病合并呼吸衰竭患者中的应用[J].海南医学,2013,4(24):1180-1182.
[6] 陈剑波,田佳,贵建平. AECOPD患者血浆BNP水平及其临床意义[J].临床肺科杂志, 2012,10(17):1063-1064.
[7] 蒋延文,庞莉,方秋红,等.血清炎性因子水平与慢性阻塞性肺疾病继发肺动脉高压的相关性研究[J]. 中华结核和呼吸杂志,2011,12(34):904-908.
[8] 陈建,张彩虹.血浆B型利尿钠肽在COPD伴肺动脉高压患者中的应用研究[J]. 中国医药科学,2011,3(1):28-29.
[9] 李芳.联合BNP、CA125和气急鉴别指数对呼吸困难的诊断价值[J].临床肺科杂志, 2012,9(17):1575-1576.
[10] 凡靖,张红,范磊等.慢性支气管炎、COPD及肺心病患者BNP、肺功能和血气变化的研究[J]. 临床肺科杂志,2012,8(17):1408-1410.
[11] 姚德志.无创机械通气对老年慢性肺心病伴呼吸衰竭患者的BNP、ET-1水平的影响[J]. 齐齐哈尔医学院学报, 2013,11(34):2347-2349.
[12] 杨异,唐映华,银联立,等. 3个项目在呼吸衰竭危重程度及预后中的诊断价值[J]. 检验医学与临床, 2013,5(10):1130-1131.
[13] 仝春冉,张中和,马春梅,等.简化肺栓塞严重性指数及生化标志物的联合检测在肺栓塞预后评价中的价值[J]. 中华结核和呼吸杂志,2014,2(37):104-108.
[14] 姚志军,陈兴旺,周华锋,等.急性呼吸窘迫综合征患者血浆脑钠肽水平与血管外肺水的相关性研究[J]. 临床内科杂志,2012,12(29):839-841.
[15] 林英,郝佳,么改琦,等.脑钠肽对急性呼吸窘迫综合征患者预后评估的价值[J]. 中国危重病急救医学,2010,22:285-287.
[16] 黄慧徐,作军.三种利钠肽水平对社区获得性肺炎患者近远期病死率预测价值的比较[J]. 中华结核和呼吸杂志,2012,9(35):682.